THOUSAND OAKS Calif. Aug. 28 2016 PRNewswire Amgen NASDAQAMGN today announced data presented at the European Society of Cardiology ESC Congress 2016 showing Repatha&174; evolocumab consistently reduced lowdensity lipoprotein cholesterol LDLC in patien...
↧